Palatin Technologies(PTN)
$6.23-0.34 (-5.18%)
PTN
Palatin Technologies stock drug pipeline
$6.23
At close:-0.34 (-5.18%)
Want to see PTN full AI Analyst Report?
Palatin Technologies (PTN) Drug Pipeline
2,935 Followers
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tirzepatide, Bremelanotide | Obesity | Phase II | Active Not Recruiting | A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity | Jun 05, 2024 | ― |
| Pl8177 | Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare | Phase II | Active Not Recruiting | Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) | May 25, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tirzepatide, Bremelanotide | Phase II | Obesity | Active Not Recruiting | A Phase 2 Study Evaluating the Co-Administration of Bremelanotide With Tirzepatide for the Treatment of Obesity | Jun 05, 2024 | ― |
| Pl8177 | Phase II | Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative, Ulcerative Colitis Flare | Active Not Recruiting | Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC) | May 25, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Palatin Technologies, Inc. (PTN) have in its pipeline
Palatin Technologies PTN is currently developing the following drugs: Tirzepatide, Bremelanotide, Pl8177. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

